Treatment of type 1 and type 2 diabetes mellitus with insulin detemir, a long-acting insulin analog.

about

Efficacy and Safety of Insulin Glargine 300 U/mL versus 100 U/mL in Diabetes Mellitus: A Comprehensive Review of the Literature.

P2860

Q52605864-8B8F372B-5148-4F37-B83C-A4634270536A

P2860

Treatment of type 1 and type 2 diabetes mellitus with insulin detemir, a long-acting insulin analog.

Item

http://www.wikidata.org/entity/Q36139042

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Treatment of type 1 and type 2 ...... a long-acting insulin analog.

@ast

Treatment of type 1 and type 2 ...... a long-acting insulin analog.

@en

type

Item

label

Treatment of type 1 and type 2 ...... a long-acting insulin analog.

@ast

Treatment of type 1 and type 2 ...... a long-acting insulin analog.

@en

prefLabel

Treatment of type 1 and type 2 ...... a long-acting insulin analog.

@ast

Treatment of type 1 and type 2 ...... a long-acting insulin analog.

@en

P1476

Treatment of type 1 and type 2 ...... a long-acting insulin analog.

@en

P2093

Carrie McAdam-Marx

http://www.w3.org/2001/XMLSchema#string

Jason R Young

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

Current antihyperglycemic treatment strategies for patients with type 2 diabetes mellitus

Genetics, pathogenesis and clinical interventions in type 1 diabetes

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

Effects of intensive glucose lowering in type 2 diabetes

Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort.

Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy.

The management of diabetic neuropathy in CKD.

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

P304

65-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4137/CMED.S5330

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22879788

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3411520

http://www.w3.org/2001/XMLSchema#string

Treatment of type 1 and type 2 diabetes mellitus with insulin detemir, a long-acting insulin analog.

about

P2860

P2860

Treatment of type 1 and type 2 diabetes mellitus with insulin detemir, a long-acting insulin analog.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932